Daily Financial Update
Good morning—it’s Friday, October 3, 2025. If you’re hitting the snooze on your portfolio, you’re missing the party. Here’s the raw, unfiltered recap and what to watch today.
Opening Recap
Market Pulse: Tech and risk assets drift as government shutdown chatter pins Treasury yields and keeps financials stuck in neutral.
Key Movers: Bitcoin ripped to fresh multi-week highs (see ‘Bitcoin hits $118.5k: All-time high could be next as rate-cut bets crush shorts‘ from CryptoSlate) while Avalanche surged on its SPAC-backed treasury bet (see ‘Avalanche rises as treasury firm eyes $1B buy after SPAC deal‘ from Cointelegraph).
Macro & Politics: Sen. Hawley fired at the FDA over generic mifepristone (Fox News) even as a generic abortion pill slipped through quietly ahead of the shutdown (see ‘FDA quietly approved a generic abortion pill ahead of shutdown‘ from NBC News), underscoring a political risk undercurrent.
What’s Next: Eyes on today’s biotech catalysts after Roche scored FDA approval for its Tecentriq combo, plus volatility around the Avalanche merger vote.
Market Commentary
Here’s what everyone’s missing: regulators could rain on crypto’s FOMO parade. Sure Bitcoin soared in ‘Bitcoin hits $118.5k: All-time high could be next as rate-cut bets crush shorts‘ (CryptoSlate) and AVAX is partying on its Avalanche SPAC deal (Crypto Briefing), but a sudden press release from Washington could flip sentiment in seconds—grim shit if you’re unprepared.
Meanwhile, the healthcare sector’s playing a political ping-pong match that should concern investors. Sen. Hawley’s diatribe against the FDA’s generic mifepristone approval (Fox News) collides with Roche’s under-the-radar win on the Tecentriq plus lurbinectedin front (GlobeNewswire), and that’s a damn textbook example of policy unpredictability that can jolt P/E multiples without warning.
At this point, you should carve out a slice for biotech drills and hedge your crypto bets. Watch that Avalanche merger vote like a hawk and have a trigger on Roche and peer catalysts—sharp as hell, because if politics goes sideways, those picks could hand you an edge others will miss.
📈 Breaking Financial News
Hawley blasts FDA approval of new abortion drug, cites safety and trust concerns
FDA approves generic Mifepristone from company Evita Solutions as Sen. Josh Hawley blasts agency for regulatory failure and endangering women's health.
Bitcoin hits $118.5k: All-time high could be next as rate-cut bets crush shorts
Bitcoin price traded near $118,500 on Thursday as a U.S. government shutdown boosted rate-cut odds, the dollar eased, and a visible short squeeze accelerated across derivatives venues. Gold printed fresh record highs around $3,895 per ounce as rate-cut pricin…
Avalanche rises as treasury firm eyes $1B buy after SPAC deal
A group of crypto investors has backed a $675 million merger deal to create an Avalanche token treasury company aiming to buy $1 billion worth of the token.
Avalanche Foundation-backed treasury firm to go public through $675 million merger deal, targets $1 billion AVAX buy
The merger could enhance institutional access to digital assets, potentially boosting AVAX adoption and integration within financial markets.
FDA approves Roche’s Tecentriq plus lurbinectedin as first-line maintenance therapy for extensive-stage small-cell lung cancer
Basel, 3 October 2025 – Roche announced today that the U.S. Food and Drug Administration has approved Tecentriq® (atezolizumab) in combination with lurbinectedin as a first-line maintenance therapy in extensive-stage small-cell lung cancer.
You WILL buy these four miners [now or when the herd panics]
BREAKING: The Senate just passed Trump’s “Big Beautiful Bill” – which guarantees the US will add another $10 trillion to its already massive debt pile. The means big beautiful gains are coming to the best gold miners – because gold runs higher and longer in times of out of control monetary inflation. Go here to learn about the four “Golden Anomaly” miners selling at discounts up to 90% below the value of their gold in the ground
🔍 Market Analysis & Insights
Bitcoin hits a 6-week high above $120,000, defying a government shutdown
Bitcoin has broken above the key $120,000 level for the first time since August. The rally is fueled by renewed optimism about macroeconomic tailwinds. BTC futures open interest has hit a record high of $32.6 billion. The bulls are back in charge.
Bitcoin’s next stop could be $125K: Here’s why
Bitcoin price aims for $125,000 as the gold rally and reduced inflation risks strengthen investors’ conviction in interest rate cuts and a rally from alternative assets.
FDA quietly approved a generic abortion pill ahead of shutdown
The FDA quietly approved a generic form of mifepristone, one of the two medications used in most U.S. abortions, on Tuesday.
Trump's call to split up the MMR vaccine revives long-settled debate
President Trump's suggestion that the combination measles, mumps and rubella vaccine should be separated marks a sharp break from decades of immunization practice.
Bitcoin Hits $120K With Traders Eyeing Bullish October Rally
Open interest in BTC futures hits all-time high as Fed uncertainty and ETF hopes boost crypto sentiment.
Alert: The DeFi Token Set to Explode as Markets Recover
Major institutions are fighting to acquire this DeFi protocol before prices surge in the post-tariff rally that's already beginning. This isn't speculation – this platform's role is so essential to crypto's financial system that its current price defies all logic. Just Released: The DeFi token set for massive gains as markets heat up – only $3!
💰 Investment Opportunities
Corporatization of healthcare gets too much of a bad rap
Healthcare analyst says outside investment can boost innovation, growth, care, but profit needs to be aligned with patient outcomes.
Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair
Neuraptive Therapeutics, Inc. announced the first patient has been enrolled in its phase 3 clinical trial using NTX-001 to improve outcomes in peripheral nerve injuries requiring surgical repair.
Bitcoin breaks $117K: Why BTC’s Q4 rally hinges on THIS factor!
BTC breaks $117k – Could FOMO drive price discovery toward $200k?
Veteran Boca Raton Florida Trial Attorney Joe Osborne Exposes “Guinea Pig” Medical Device System Putting Patients at Risk
Exclusive Interview by Coffee With Q News Host Rene Perras with leading Boca Raton personal injury lawyer Joe Osborne on risky medical device systems.